Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TLRY
Strong SellSinkerTilray Brands, Inc. · Healthcare · Canada · $631M · Avg Vol: $20M/d
COMPANY DESCRIPTION
Tilray Brands, Inc. is a global cannabis lifestyle and consumer packaged goods company, operating across cannabis cultivation, processing, and distribution, as well as craft beverages. It produces and markets a portfolio of cannabis brands, medical cannabis products, and hemp-based foods and beverages in North America and Europe. As a market leader in the evolving global cannabis industry, Tilray leverages its extensive international infrastructure and diverse brand portfolio to capture market share.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 628.4M | 627.1M | 788.9M | 821.3M | 9.3% | 915.5M | 1.0B | 1.1B | 8.7% |
| EPS | -3.88 | -23.50 | -3.30 | -24.60 | — | -1.09 | — | — | — |
| Shares | 123.5M | 65.7M | 83.2M | 105.9M | -14.2% | 137.6M | — | — | — |
| Debt | 623.8M | 590.1M | 387.3M | 328.7M | -19.2% | 343.9M | — | — | — |
| Equity | 4.4B | 3.3B | 3.4B | 1.5B | -30.0% | — | — | — | — |
| Op CF | -177.3M | 7.9M | -30.9M | -94.6M | — | -69.1M | — | — | — |
| Inv CF | -21.5M | -285.1M | 128.3M | -46.7M | — | — | — | — | — |
| Fin CF | 128.2M | 70.2M | -75.2M | 133.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TLRY are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TLRY | Tilray Brands, Inc.(you) | $631M | 13 | Strong Sell |
| CGC | Canopy Growth Corporation | $475M | 19 | Strong Sell |
| CRDL.TO | Cardiol Therapeutics Inc. | $252M | 23 | Sell |
| ACB | Aurora Cannabis Inc. | $254M | 35 | Hold |
| NVRS.CN | Noveris Health Sciences Inc. | $55M | 3 | Strong Sell |
| LSL.V | LSL Pharma Group Inc. | $30M | 15 | Strong Sell |
| GUD.TO | Knight Therapeutics Inc. | $682M | 76 | Buy |
| OPTI.CN | Optimi Health Corp. | $27M | 12 | Strong Sell |
| TSND.TO | TerrAscend Corp. | $243M | 60 | Hold |
| CRON | Cronos Group Inc. | $1.2B | 68 | Buy |
Peer medians: ROE -37.9% · P/E 17.3x · Gross margin 46.2%